Read Larry Connors' blog – Short Term Trading Strategies
Cytori Therapeutics Inc (NASDAQ: CYTX | Quote | Chart | News | PowerRating) engages in the development, manufacture, and sale of medical technologies to enable the practice of regenerative medicine. The company develops its product pipeline for the treatment of cardiovascular disease, orthopedic damage, gastrointestinal disorders, and pelvic health. Its principal products include the Celution System family of products, which processes patients' cells at the bedside in real time. Each member of the Celution System family of products consists of a central device, a related single-use consumable used for each patient procedure, and supportive procedural components. The company also offers Celution 800/CRS System for the European reconstructive surgery market through a network of medical distributors; and the Celution 900/MB in Japan through its commercialization partner as part of the StemSource Cell Bank, which prepares cells for cryopreservation. Cytori Therapeutics is conducting two clinical trials on adipose-derived stem and regenerative cells processed with the Celution 600 System in patients suffering from chronic myocardial ischemia and in heart attack patients. In addition, it develops and sells thin film bioresorbable implants in Japan. Further, the company operates a tissue bank facility for the preservation of stem and regenerative cells extracted from adipose tissue. Additionally, it has a joint venture with Olympus Corporation to develop and manufacture second generation devices based on its Celution system. Cytori Therapeutics has a collaboration agreement with Fraunhofer Institute For Cell Therapy And Immunology to develop adipose-derived stem and regenerative cell-based treatments for ischemic stroke. The company was founded in 1996. It was formerly known as MacroPore, Inc. and changed its name to MacroPore Biosurgery, Inc. Further, the company changed its name to Cytori Therapeutics, Inc. in 2005. Cytori Therapeutics is headquartered in San Diego, California. With 25.1 million shares outstanding and 863,600 shares declared short as of May 2008, there is a failure to deliver in shares of CYTX. According to quarterly data provided by the SEC, there were still 176,406 shares of CYTX that were failing-to-deliver as of September 28, 2007.
Citizens & Northern Corp (NASDAQ: CZNC | Quote | Chart | News | PowerRating) operates as the holding for Citizens & Northern Bank and First State Bank, which provide various banking and mortgage services to individual and corporate customers in north central Pennsylvania and southern New York. Its deposit products include various checking accounts, passbook and statement savings, money market accounts, interest checking accounts, individual retirement accounts, and certificates of deposits, as well as non-insured Repo Sweep accounts. The company's loan portfolio comprises mortgage loans, commercial loans, and consumer loans, as well as specialized instruments, such as commercial letters-of-credit. It also provides trust and financial management services, including administration of trusts and estates, such as estate planning, estate settlements, and asset management; and 401(k) plans, retirement plans, other employee benefit plans, and investment management services, as well as various personal and commercial insurance products, as well as mutual funds, annuities, educational savings accounts, and other investment products through registered agents. The company was founded in 1971 and is based in Wellsboro, Pennsylvania. With 8.97 million shares outstanding and 15,200 shares declared short as of May 2008, there is a failure to deliver in shares of CZNC.
Diamond Hill Investment Group Inc. (NASDAQ: DHIL | Quote | Chart | News | PowerRating) through its subsidiary, Diamond Hill Capital Management, Inc., provides investment advisory services in the United States. It serves individuals and institutional investors through the Diamond Hill sponsored mutual funds, separate accounts, and private investment funds. The company's portfolio strategies under management include small cap, small-mid cap, large cap, select, long-short, financial long-short, and strategic income. Diamond Hill Investment distributes its products through financial intermediaries, including independent registered investment advisors, brokers, financial planners, investment consultants, and third party marketing firms. The company was founded in 1990 and is based in Columbus, Ohio. With 2.36 million shares outstanding and 6,100 shares declared short as of May 2008, there is a failure to deliver in shares of DHIL.
ESSA Bancorp Inc. (NASDAQ: ESSA | Quote | Chart | News | PowerRating) operates as the holding company for ESSA Bank & Trust that provides financial services to individuals, families, and businesses Pennsylvania. It generates various deposit products, including savings accounts, NOW accounts, checking accounts, money market accounts, club accounts, certificates of deposit, individual retirement accounts, and other qualified plan accounts. The company provides residential first mortgage loans, including construction mortgage loans; commercial real estate; home equity loans and lines of credit; and commercial and consumer loans, as well as various loans unsecured or secured by deposits, personal loans, and automobile loans. It also offers asset management and trust services, as well as provides investment services through the relationship with PRIMEVEST Financial Services, Inc., a third party broker/dealer and investment advisor. In addition, the company trades in agency securities, mortgage-backed securities, and corporate debt obligations. ESSA Bancorp serves its customers through 13 full-service banking offices located in Monroe and Northampton Counties, Pennsylvania. The company was founded in 1916 and is based in Stroudsburg, Pennsylvania. With 16.98 million shares outstanding and 11,000 shares declared short as of May 2008, there is a failure to deliver in shares of ESSA. According to quarterly data provided by the SEC, there were still 74,989 shares of ESSA that were failing-to-deliver as of August 13, 2007.
ev3 Inc. (NASDAQ: EVVV | Quote | Chart | News | PowerRating) a medical device company, focuses on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. It develops, manufactures, and markets a range of products that include stents, atherectomy and thrombectomy products, balloon angioplasty catheters, microcatheters and occlusion balloon systems, embolic protection devices, infusion catheters/wires, embolic coils, and liquid embolics. The company markets its products in the United States, Europe, and Canada through a direct sales force, and through distributors in the United States and international markets. ev3, Inc. has a research collaboration with Merck & Co., Inc. for the analysis of atherosclerotic plaque removed from patient arteries with the goal of identifying new biomarkers of atherosclerotic disease progression and new therapies for atherosclerotic disease. The company is headquartered in Plymouth, Minnesota. With 105.22 million shares outstanding and 9.37 million shares declared short as of May 2008, there is a failure to deliver in shares of EVVV. According to quarterly data provided by the SEC, there were still 31,556 shares of EVVV that were failing-to-deliver as of September 27, 2007.
FuelCell Energy Inc. (NASDAQ: FCEL | Quote | Chart | News | PowerRating) engages in the development and manufacture of fuel cell power plants for electric power generation. Its core carbonate fuel cell products include Direct FuelCell or DFC Power Plants for stationary power generation applications. The company also develops carbonate fuel cell, hybrid products, and planar solid oxide fuel cell technology. Its proprietary carbonate DFC power plants electrochemically produce electricity directly from readily available hydrocarbon fuels, such as natural gas and biogas fuels. The company serves manufacturers; mission critical institutions, including correction facilities and government; and hotels and customers, such as breweries, food processors, and wastewater treatment facilities who use renewable gas for fuel. FuelCell Energy, Inc. has operations in the United States, Canada, Germany, Japan, and South Korea. The company was founded in 1969 and is headquartered in Danbury, Connecticut. With 68.58 million shares outstanding and 13.7 million shares declared short as of May 2008, there is a failure to deliver in shares of FCEL. According to quarterly data provided by the SEC, there were still 82,651 shares of FCEL that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CYTX has previously paid a $995.00 data fee to BUYINS.NET. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
